Poultry Probiotics Market is set to surpass USD 125 million by 2025

Over the past few years, livestock production has increased exponentially. This has indeed made a subsequent impact on poultry probiotics market, with the increasing demand for NGPs (natural growth promoters) in animal feed. Poultry probiotics industry is strongly characterized by R&D and product innovation activities, which have made this fraternity witness a fiercely competitive landscape. The industry players are constantly involved in implementing growth strategies such as global expansion and product development to sustain their market value.  Below is a synopsis of the contributions by the key participants toward the growth of poultry probiotics market:

 

Two of the prominent global leaders in poultry probiotics industry, Adisseo and Novozymes, have launched their probiotic called Alterion, especially for poultry application. Made from all the naturally-occurring bacterium found in soil, use of Alterion in the animal feed has helped the farmers to better control the gut health of their animals. It also prevents the growth of unwanted bacteria in the digestive tract of animals and optimizes the feed conversion by 2% to 2.5%.

Both the firms are striving to expand their global reach in this rapidly developing market. In 2016, Alterion, was introduced in the U.S. and later in the countries of South East Asia and Middle East.

Currently, U.S. is witnessing a strong demand for streptococcus based poultry probiotics as it increases animal weight and enhances their feed conversion. As per estimates, U.S. poultry probiotics market from the demand of streptococcus is projected to generate revenue worth over USD 25 million by 2024.

Boehringer Ingelheim Animal Health and Novozymes have created a vibrant buzz in poultry probiotics market, by announcing their plan to collaborate and commercialize probiotics for global poultry production. This announcement of Boehringer Ingelheim to join forces with Novozymes- the renowned biological solutions provider, enabled the former to foray into animal feed additives market, which is profoundly challenged by antibiotic bans.

Stringent regulations by EU Commission and the FDA toward the ban of AGPs in animal feed have positively influenced the global poultry probiotics market trends.

The collaboration is indeed an appreciable step taken by the companies to enhance their market value in terms of capabilities, product innovation, and pricing strategy. With this move, Novozymes is expected to utilize Boehringer Ingelheim’s vast network to gain access to new distribution channels and customers across the globe.

Evonik, a leading player in poultry probiotics industry has launched its first probiotic product called GutCare PY1. The company, being a specialist in feed amino acids, plans to take the lead in the field of developing sustainable and antibiotic-free livestock feed additives. Presently, Evonik holds three probiotics in its portfolio, viz. Ecobiol for poultry, Fecinor for piglets, and the newly launched GutCare PY1. Expanding the product portfolio has complemented the company with a better accessibility to the customers at a global scale. Evonik plans to initially introduce the product in the U.S. poultry probiotics market and gradually in the Asia Pacific belt.

Chr. Hansen is amongst one of the world’s top three manufacturers of probiotics for animals, along with Dupont and Lallemand.

The under growing pressure to use fewer antibiotics in the food chain has been an important driver for the growth of poultry probiotics market. This company is grabbing a huge opportunity from the growing demand for antibiotic-free poultry and is expanding its animal nutrition portfolio in Asia Pacific market.

Asia Pacific is one of the chief regions witnessing a phenomenal expansion of animal health industry. Countries such as Australia, South Korea, India, and China are comparatively mature in terms of usage of probiotics in feed.

As per a report, China poultry probiotics industry is projected to generate revenue over USD 250 million by 2024, owing to rising consumption of broiler meat and rise in per-capita disposable income.

Chr. Hansen is actively planning to launch its product in China & US poultry probiotics market as an alternative to antibiotics, as these countries bet big in terms of swine and chicken sectors globally.

These trends vividly validate the potential of poultry probiotics industry in the coming years. As per a  report by Global Market Insights, Inc., Poultry Probiotics Industry is projected to register a CAGR of 7% over 2016-2024, surpassing a valuation of USD 1.8 billion by 2024.